Until Labs
until
United States · $58.0M raised
- Business Model
- B2B
- Website
- untillabs.com
- Total Funding
- $58.0M
- Last Round
- $58.0M Series AJan 2025
- Rounds
- 1
About
Building reversible cryopreservation technology to preserve and restore biological systems.
Summary
Until Labs is a Biotech company based in United States. It has raised $58.0M in total across 1 round, most recently a $58.0M Series A round in Jan 2025. Investors include Founders Fund and Lux Capital.
Tech & App Stack
17 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...